Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Presentation TVT 2016

Severe Chronic Kidney Disease and TAVR: Clinical Management Recommendations

Presenter: Ganesh Manoharan

June 17, 2016

Presentation

AKI in Patients With Chronic Kidney Disease Undergoing Internal CAS Implantation

Presenter: M. Donahue

September 25, 2015

Presentation

Net Clinical Benefit of Antithrombotic Therapy in Patients With A-fib and Chronic Kidney Disease

Presenter: Nissen Bonde

December 08, 2014

Presentation TCT 2014

Case Presentation: A Complex Patient at High Risk for Contrast-Induced Nephropathy

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon, Graham A. Cassel

September 16, 2014

Presentation TCT 2014

Access Site and the Risk of Acute Kidney Injury

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon, Hitinder S. Gurm

September 16, 2014

Presentation TCT 2014

Clinical Trial Updates: RenalGuard, AVERT, etc.

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon

September 16, 2014

Presentation TCT 2014

Renal Denervation for Chronic Kidney Disease: Status and Case Example

Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi, Felix Mahfoud

September 14, 2014

Presentation TCT 2013

Trend of clinical outcomes in patients with chronic kidney disease and end-stage renal disease following percutaneous coronary intervention.

Presenter: James Lai, M. Chadi Alraies, Wael Aljaroudi, Stephen Ellis, Leslie Cho

January 31, 2013

Presentation TCT 2013

Impact of pre-operative chronic kidney disease on transcatheter aortic valve implantation outcome

Presenter: Nicolas DUMONTEIL, Alaide Chieffo, Didier Tchetche, Nicolas Van Mieghem, Bertrand Marcheix, Robert M A Van Der Boon, Gill Buchanan, Olivier Vahdat, Patrick Serruys, Jean Fajadet, Peter De Jaegere, Antonio Colombo, Didier Carri?

January 31, 2013

Presentation TCT 2012

Objectives: The purpose of this study was to determine the functional impact of cilostazol in patients with chronic kidney disease (CKD) undergoing hemodialysis.

Presenter: Weon Kim, Won-Yu Kang, Jong-Shin Woo

January 03, 2012

Presentation TCT 2012

Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients with Chronic Kidney Disease: A Report From the National Heart, Lung, and Blood...

Presenter: Joseph Kim, Helen Vlachos, Suresh R. Mulukutla, Catalin Toma, Joon S. Lee, David O. Williams, Sheryl F. Kelsey, Kevin E. Kip, Oscar C. Marroquin

January 03, 2012

Advertisement

Severe Chronic Kidney Disease and TAVR: Clinical Management Recommendations

AKI in Patients With Chronic Kidney Disease Undergoing Internal CAS Implantation

Net Clinical Benefit of Antithrombotic Therapy in Patients With A-fib and Chronic Kidney Disease

Case Presentation: A Complex Patient at High Risk for Contrast-Induced Nephropathy

Access Site and the Risk of Acute Kidney Injury

Clinical Trial Updates: RenalGuard, AVERT, etc.

Renal Denervation for Chronic Kidney Disease: Status and Case Example

Trend of clinical outcomes in patients with chronic kidney disease and end-stage renal disease following percutaneous coronary intervention.

Impact of pre-operative chronic kidney disease on transcatheter aortic valve implantation outcome

Objectives: The purpose of this study was to determine the functional impact of cilostazol in patients with chronic kidney disease (CKD) undergoing hemodialysis.

Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients with Chronic Kidney Disease: A Report From the National Heart, Lung, and Blood...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content